aluates Reports

$ 0.0

Automative

Global Real World Evidence Solutions(RWE) for Oncology Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-8W14113

Global Real World Evidence Solutions RWE for Oncology Market Research Report 2023

BUY CHAPTERS

Global Real World Evidence Solutions(RWE) for Oncology Market Research Report 2025

Code: QYRE-Auto-8W14113

Report

May 2025

Pages:71

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Anthem

IMS Health

ICON

Thermo Fisher Scientific

Clinigen

Cognizant

Oracle

PAREXEL

PerkinElmer Inc

IBM

Real World Evidence Solutions(RWE) for Oncology Market Size

The global market for Real World Evidence Solutions(RWE) for Oncology was valued at US$ 1135 million in the year 2024 and is projected to reach a revised size of US$ 2608 million by 2031, growing at a CAGR of 12.8% during the forecast period.

Real World Evidence Solutions(RWE) for Oncology Market

North American market for Real World Evidence Solutions(RWE) for Oncology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Real World Evidence Solutions(RWE) for Oncology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Real World Evidence Solutions(RWE) for Oncology in Breast Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Real World Evidence Solutions(RWE) for Oncology include Anthem, IMS Health, ICON Plc, Thermo Fisher Scientific, Clinigen, Cognizant, Oracle, Parexel, PerkinElmer, IBM, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Real World Evidence Solutions(RWE) for Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Real World Evidence Solutions(RWE) for Oncology.

The Real World Evidence Solutions(RWE) for Oncology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Real World Evidence Solutions(RWE) for Oncology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Real World Evidence Solutions(RWE) for Oncology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Real World Evidence Solutions(RWE) for Oncology Market Report

Report Metric	Details
Report Name	Real World Evidence Solutions(RWE) for Oncology Market
Accounted market size in year	US$ 1135 million
Forecasted market size in 2031	US$ 2608 million
CAGR	12.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Electronic Health Record(EHR) Integrated Dataset Others
Segment by Application	Breast Cancer Lung Cancer Prostate Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Anthem, IMS Health, ICON Plc, Thermo Fisher Scientific, Clinigen, Cognizant, Oracle, Parexel, PerkinElmer, IBM
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Real World Evidence Solutions(RWE) for Oncology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Real World Evidence Solutions(RWE) for Oncology Market growing?

Ans: The Real World Evidence Solutions(RWE) for Oncology Market witnessing a CAGR of 12.8% during the forecast period 2025-2031.

What is the Real World Evidence Solutions(RWE) for Oncology Market size in 2031?

Ans: The Real World Evidence Solutions(RWE) for Oncology Market size in 2031 will be US$ 2608 million.

Who are the main players in the Real World Evidence Solutions(RWE) for Oncology Market report?

Ans: The main players in the Real World Evidence Solutions(RWE) for Oncology Market are Anthem, IMS Health, ICON Plc, Thermo Fisher Scientific, Clinigen, Cognizant, Oracle, Parexel, PerkinElmer, IBM

What are the Application segmentation covered in the Real World Evidence Solutions(RWE) for Oncology Market report?

Ans: The Applications covered in the Real World Evidence Solutions(RWE) for Oncology Market report are Breast Cancer, Lung Cancer, Prostate Cancer, Others

What are the Type segmentation covered in the Real World Evidence Solutions(RWE) for Oncology Market report?

Ans: The Types covered in the Real World Evidence Solutions(RWE) for Oncology Market report are Electronic Health Record(EHR), Integrated Dataset, Others

Recommended Reports

Cancer Diagnostics

Cancer Therapies

Oncology Market Solutions

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Real World Evidence Solutions(RWE) for Oncology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Electronic Health Record(EHR)

1.2.3 Integrated Dataset

1.2.4 Others

1.3 Market by Application

1.3.1 Global Real World Evidence Solutions(RWE) for Oncology Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Breast Cancer

1.3.3 Lung Cancer

1.3.4 Prostate Cancer

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Real World Evidence Solutions(RWE) for Oncology Market Perspective (2020-2031)

2.2 Global Real World Evidence Solutions(RWE) for Oncology Growth Trends by Region

2.2.1 Global Real World Evidence Solutions(RWE) for Oncology Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Real World Evidence Solutions(RWE) for Oncology Historic Market Size by Region (2020-2025)

2.2.3 Real World Evidence Solutions(RWE) for Oncology Forecasted Market Size by Region (2026-2031)

2.3 Real World Evidence Solutions(RWE) for Oncology Market Dynamics

2.3.1 Real World Evidence Solutions(RWE) for Oncology Industry Trends

2.3.2 Real World Evidence Solutions(RWE) for Oncology Market Drivers

2.3.3 Real World Evidence Solutions(RWE) for Oncology Market Challenges

2.3.4 Real World Evidence Solutions(RWE) for Oncology Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Real World Evidence Solutions(RWE) for Oncology Players by Revenue

3.1.1 Global Top Real World Evidence Solutions(RWE) for Oncology Players by Revenue (2020-2025)

3.1.2 Global Real World Evidence Solutions(RWE) for Oncology Revenue Market Share by Players (2020-2025)

3.2 Global Real World Evidence Solutions(RWE) for Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Real World Evidence Solutions(RWE) for Oncology Revenue

3.4 Global Real World Evidence Solutions(RWE) for Oncology Market Concentration Ratio

3.4.1 Global Real World Evidence Solutions(RWE) for Oncology Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Real World Evidence Solutions(RWE) for Oncology Revenue in 2024

3.5 Global Key Players of Real World Evidence Solutions(RWE) for Oncology Head office and Area Served

3.6 Global Key Players of Real World Evidence Solutions(RWE) for Oncology, Product and Application

3.7 Global Key Players of Real World Evidence Solutions(RWE) for Oncology, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Real World Evidence Solutions(RWE) for Oncology Breakdown Data by Type

4.1 Global Real World Evidence Solutions(RWE) for Oncology Historic Market Size by Type (2020-2025)

4.2 Global Real World Evidence Solutions(RWE) for Oncology Forecasted Market Size by Type (2026-2031)

5 Real World Evidence Solutions(RWE) for Oncology Breakdown Data by Application

5.1 Global Real World Evidence Solutions(RWE) for Oncology Historic Market Size by Application (2020-2025)

5.2 Global Real World Evidence Solutions(RWE) for Oncology Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Real World Evidence Solutions(RWE) for Oncology Market Size (2020-2031)

6.2 North America Real World Evidence Solutions(RWE) for Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Real World Evidence Solutions(RWE) for Oncology Market Size by Country (2020-2025)

6.4 North America Real World Evidence Solutions(RWE) for Oncology Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Real World Evidence Solutions(RWE) for Oncology Market Size (2020-2031)

7.2 Europe Real World Evidence Solutions(RWE) for Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Real World Evidence Solutions(RWE) for Oncology Market Size by Country (2020-2025)

7.4 Europe Real World Evidence Solutions(RWE) for Oncology Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Real World Evidence Solutions(RWE) for Oncology Market Size (2020-2031)

8.2 Asia-Pacific Real World Evidence Solutions(RWE) for Oncology Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Real World Evidence Solutions(RWE) for Oncology Market Size by Region (2020-2025)

8.4 Asia-Pacific Real World Evidence Solutions(RWE) for Oncology Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Real World Evidence Solutions(RWE) for Oncology Market Size (2020-2031)

9.2 Latin America Real World Evidence Solutions(RWE) for Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Real World Evidence Solutions(RWE) for Oncology Market Size by Country (2020-2025)

9.4 Latin America Real World Evidence Solutions(RWE) for Oncology Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Real World Evidence Solutions(RWE) for Oncology Market Size (2020-2031)

10.2 Middle East & Africa Real World Evidence Solutions(RWE) for Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Real World Evidence Solutions(RWE) for Oncology Market Size by Country (2020-2025)

10.4 Middle East & Africa Real World Evidence Solutions(RWE) for Oncology Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Anthem

11.1.1 Anthem Company Details

11.1.2 Anthem Business Overview

11.1.3 Anthem Real World Evidence Solutions(RWE) for Oncology Introduction

11.1.4 Anthem Revenue in Real World Evidence Solutions(RWE) for Oncology Business (2020-2025)

11.1.5 Anthem Recent Development

11.2 IMS Health

11.2.1 IMS Health Company Details

11.2.2 IMS Health Business Overview

11.2.3 IMS Health Real World Evidence Solutions(RWE) for Oncology Introduction

11.2.4 IMS Health Revenue in Real World Evidence Solutions(RWE) for Oncology Business (2020-2025)

11.2.5 IMS Health Recent Development

11.3 ICON Plc

11.3.1 ICON Plc Company Details

11.3.2 ICON Plc Business Overview

11.3.3 ICON Plc Real World Evidence Solutions(RWE) for Oncology Introduction

11.3.4 ICON Plc Revenue in Real World Evidence Solutions(RWE) for Oncology Business (2020-2025)

11.3.5 ICON Plc Recent Development

11.4 Thermo Fisher Scientific

11.4.1 Thermo Fisher Scientific Company Details

11.4.2 Thermo Fisher Scientific Business Overview

11.4.3 Thermo Fisher Scientific Real World Evidence Solutions(RWE) for Oncology Introduction

11.4.4 Thermo Fisher Scientific Revenue in Real World Evidence Solutions(RWE) for Oncology Business (2020-2025)

11.4.5 Thermo Fisher Scientific Recent Development

11.5 Clinigen

11.5.1 Clinigen Company Details

11.5.2 Clinigen Business Overview

11.5.3 Clinigen Real World Evidence Solutions(RWE) for Oncology Introduction

11.5.4 Clinigen Revenue in Real World Evidence Solutions(RWE) for Oncology Business (2020-2025)

11.5.5 Clinigen Recent Development

11.6 Cognizant

11.6.1 Cognizant Company Details

11.6.2 Cognizant Business Overview

11.6.3 Cognizant Real World Evidence Solutions(RWE) for Oncology Introduction

11.6.4 Cognizant Revenue in Real World Evidence Solutions(RWE) for Oncology Business (2020-2025)

11.6.5 Cognizant Recent Development

11.7 Oracle

11.7.1 Oracle Company Details

11.7.2 Oracle Business Overview

11.7.3 Oracle Real World Evidence Solutions(RWE) for Oncology Introduction

11.7.4 Oracle Revenue in Real World Evidence Solutions(RWE) for Oncology Business (2020-2025)

11.7.5 Oracle Recent Development

11.8 Parexel

11.8.1 Parexel Company Details

11.8.2 Parexel Business Overview

11.8.3 Parexel Real World Evidence Solutions(RWE) for Oncology Introduction

11.8.4 Parexel Revenue in Real World Evidence Solutions(RWE) for Oncology Business (2020-2025)

11.8.5 Parexel Recent Development

11.9 PerkinElmer

11.9.1 PerkinElmer Company Details

11.9.2 PerkinElmer Business Overview

11.9.3 PerkinElmer Real World Evidence Solutions(RWE) for Oncology Introduction

11.9.4 PerkinElmer Revenue in Real World Evidence Solutions(RWE) for Oncology Business (2020-2025)

11.9.5 PerkinElmer Recent Development

11.10 IBM

11.10.1 IBM Company Details

11.10.2 IBM Business Overview

11.10.3 IBM Real World Evidence Solutions(RWE) for Oncology Introduction

11.10.4 IBM Revenue in Real World Evidence Solutions(RWE) for Oncology Business (2020-2025)

11.10.5 IBM Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Anthem

IMS Health

ICON

Thermo Fisher Scientific

Clinigen

Cognizant

Oracle

PAREXEL

PerkinElmer Inc

IBM

List of Tables

Table 1. Global Real World Evidence Solutions(RWE) for Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Electronic Health Record(EHR)

Table 3. Key Players of Integrated Dataset

Table 4. Key Players of Others

Table 5. Global Real World Evidence Solutions(RWE) for Oncology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Real World Evidence Solutions(RWE) for Oncology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Real World Evidence Solutions(RWE) for Oncology Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Real World Evidence Solutions(RWE) for Oncology Market Share by Region (2020-2025)

Table 9. Global Real World Evidence Solutions(RWE) for Oncology Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Real World Evidence Solutions(RWE) for Oncology Market Share by Region (2026-2031)

Table 11. Real World Evidence Solutions(RWE) for Oncology Market Trends

Table 12. Real World Evidence Solutions(RWE) for Oncology Market Drivers

Table 13. Real World Evidence Solutions(RWE) for Oncology Market Challenges

Table 14. Real World Evidence Solutions(RWE) for Oncology Market Restraints

Table 15. Global Real World Evidence Solutions(RWE) for Oncology Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Real World Evidence Solutions(RWE) for Oncology Market Share by Players (2020-2025)

Table 17. Global Top Real World Evidence Solutions(RWE) for Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Real World Evidence Solutions(RWE) for Oncology as of 2024)

Table 18. Ranking of Global Top Real World Evidence Solutions(RWE) for Oncology Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Real World Evidence Solutions(RWE) for Oncology Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Real World Evidence Solutions(RWE) for Oncology, Headquarters and Area Served

Table 21. Global Key Players of Real World Evidence Solutions(RWE) for Oncology, Product and Application

Table 22. Global Key Players of Real World Evidence Solutions(RWE) for Oncology, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Real World Evidence Solutions(RWE) for Oncology Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Real World Evidence Solutions(RWE) for Oncology Revenue Market Share by Type (2020-2025)

Table 26. Global Real World Evidence Solutions(RWE) for Oncology Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Real World Evidence Solutions(RWE) for Oncology Revenue Market Share by Type (2026-2031)

Table 28. Global Real World Evidence Solutions(RWE) for Oncology Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Real World Evidence Solutions(RWE) for Oncology Revenue Market Share by Application (2020-2025)

Table 30. Global Real World Evidence Solutions(RWE) for Oncology Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Real World Evidence Solutions(RWE) for Oncology Revenue Market Share by Application (2026-2031)

Table 32. North America Real World Evidence Solutions(RWE) for Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Real World Evidence Solutions(RWE) for Oncology Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Real World Evidence Solutions(RWE) for Oncology Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Real World Evidence Solutions(RWE) for Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Real World Evidence Solutions(RWE) for Oncology Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Real World Evidence Solutions(RWE) for Oncology Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Real World Evidence Solutions(RWE) for Oncology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Real World Evidence Solutions(RWE) for Oncology Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Real World Evidence Solutions(RWE) for Oncology Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Real World Evidence Solutions(RWE) for Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Real World Evidence Solutions(RWE) for Oncology Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Real World Evidence Solutions(RWE) for Oncology Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Real World Evidence Solutions(RWE) for Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Real World Evidence Solutions(RWE) for Oncology Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Real World Evidence Solutions(RWE) for Oncology Market Size by Country (2026-2031) & (US$ Million)

Table 47. Anthem Company Details

Table 48. Anthem Business Overview

Table 49. Anthem Real World Evidence Solutions(RWE) for Oncology Product

Table 50. Anthem Revenue in Real World Evidence Solutions(RWE) for Oncology Business (2020-2025) & (US$ Million)

Table 51. Anthem Recent Development

Table 52. IMS Health Company Details

Table 53. IMS Health Business Overview

Table 54. IMS Health Real World Evidence Solutions(RWE) for Oncology Product

Table 55. IMS Health Revenue in Real World Evidence Solutions(RWE) for Oncology Business (2020-2025) & (US$ Million)

Table 56. IMS Health Recent Development

Table 57. ICON Plc Company Details

Table 58. ICON Plc Business Overview

Table 59. ICON Plc Real World Evidence Solutions(RWE) for Oncology Product

Table 60. ICON Plc Revenue in Real World Evidence Solutions(RWE) for Oncology Business (2020-2025) & (US$ Million)

Table 61. ICON Plc Recent Development

Table 62. Thermo Fisher Scientific Company Details

Table 63. Thermo Fisher Scientific Business Overview

Table 64. Thermo Fisher Scientific Real World Evidence Solutions(RWE) for Oncology Product

Table 65. Thermo Fisher Scientific Revenue in Real World Evidence Solutions(RWE) for Oncology Business (2020-2025) & (US$ Million)

Table 66. Thermo Fisher Scientific Recent Development

Table 67. Clinigen Company Details

Table 68. Clinigen Business Overview

Table 69. Clinigen Real World Evidence Solutions(RWE) for Oncology Product

Table 70. Clinigen Revenue in Real World Evidence Solutions(RWE) for Oncology Business (2020-2025) & (US$ Million)

Table 71. Clinigen Recent Development

Table 72. Cognizant Company Details

Table 73. Cognizant Business Overview

Table 74. Cognizant Real World Evidence Solutions(RWE) for Oncology Product

Table 75. Cognizant Revenue in Real World Evidence Solutions(RWE) for Oncology Business (2020-2025) & (US$ Million)

Table 76. Cognizant Recent Development

Table 77. Oracle Company Details

Table 78. Oracle Business Overview

Table 79. Oracle Real World Evidence Solutions(RWE) for Oncology Product

Table 80. Oracle Revenue in Real World Evidence Solutions(RWE) for Oncology Business (2020-2025) & (US$ Million)

Table 81. Oracle Recent Development

Table 82. Parexel Company Details

Table 83. Parexel Business Overview

Table 84. Parexel Real World Evidence Solutions(RWE) for Oncology Product

Table 85. Parexel Revenue in Real World Evidence Solutions(RWE) for Oncology Business (2020-2025) & (US$ Million)

Table 86. Parexel Recent Development

Table 87. PerkinElmer Company Details

Table 88. PerkinElmer Business Overview

Table 89. PerkinElmer Real World Evidence Solutions(RWE) for Oncology Product

Table 90. PerkinElmer Revenue in Real World Evidence Solutions(RWE) for Oncology Business (2020-2025) & (US$ Million)

Table 91. PerkinElmer Recent Development

Table 92. IBM Company Details

Table 93. IBM Business Overview

Table 94. IBM Real World Evidence Solutions(RWE) for Oncology Product

Table 95. IBM Revenue in Real World Evidence Solutions(RWE) for Oncology Business (2020-2025) & (US$ Million)

Table 96. IBM Recent Development

Table 97. Research Programs/Design for This Report

Table 98. Key Data Information from Secondary Sources

Table 99. Key Data Information from Primary Sources

Table 100. Authors List of This Report

List of Figures

Figure 1. Real World Evidence Solutions(RWE) for Oncology Picture

Figure 2. Global Real World Evidence Solutions(RWE) for Oncology Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Real World Evidence Solutions(RWE) for Oncology Market Share by Type: 2024 VS 2031

Figure 4. Electronic Health Record(EHR) Features

Figure 5. Integrated Dataset Features

Figure 6. Others Features

Figure 7. Global Real World Evidence Solutions(RWE) for Oncology Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Real World Evidence Solutions(RWE) for Oncology Market Share by Application: 2024 VS 2031

Figure 9. Breast Cancer Case Studies

Figure 10. Lung Cancer Case Studies

Figure 11. Prostate Cancer Case Studies

Figure 12. Others Case Studies

Figure 13. Real World Evidence Solutions(RWE) for Oncology Report Years Considered

Figure 14. Global Real World Evidence Solutions(RWE) for Oncology Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Real World Evidence Solutions(RWE) for Oncology Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Real World Evidence Solutions(RWE) for Oncology Market Share by Region: 2024 VS 2031

Figure 17. Global Real World Evidence Solutions(RWE) for Oncology Market Share by Players in 2024

Figure 18. Global Top Real World Evidence Solutions(RWE) for Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Real World Evidence Solutions(RWE) for Oncology as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Real World Evidence Solutions(RWE) for Oncology Revenue in 2024

Figure 20. North America Real World Evidence Solutions(RWE) for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Real World Evidence Solutions(RWE) for Oncology Market Share by Country (2020-2031)

Figure 22. United States Real World Evidence Solutions(RWE) for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Real World Evidence Solutions(RWE) for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Real World Evidence Solutions(RWE) for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Real World Evidence Solutions(RWE) for Oncology Market Share by Country (2020-2031)

Figure 26. Germany Real World Evidence Solutions(RWE) for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Real World Evidence Solutions(RWE) for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Real World Evidence Solutions(RWE) for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Real World Evidence Solutions(RWE) for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Real World Evidence Solutions(RWE) for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Real World Evidence Solutions(RWE) for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Real World Evidence Solutions(RWE) for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Real World Evidence Solutions(RWE) for Oncology Market Share by Region (2020-2031)

Figure 34. China Real World Evidence Solutions(RWE) for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Real World Evidence Solutions(RWE) for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Real World Evidence Solutions(RWE) for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Real World Evidence Solutions(RWE) for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Real World Evidence Solutions(RWE) for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Real World Evidence Solutions(RWE) for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Real World Evidence Solutions(RWE) for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Real World Evidence Solutions(RWE) for Oncology Market Share by Country (2020-2031)

Figure 42. Mexico Real World Evidence Solutions(RWE) for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Real World Evidence Solutions(RWE) for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Real World Evidence Solutions(RWE) for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Real World Evidence Solutions(RWE) for Oncology Market Share by Country (2020-2031)

Figure 46. Turkey Real World Evidence Solutions(RWE) for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Real World Evidence Solutions(RWE) for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Real World Evidence Solutions(RWE) for Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Anthem Revenue Growth Rate in Real World Evidence Solutions(RWE) for Oncology Business (2020-2025)

Figure 50. IMS Health Revenue Growth Rate in Real World Evidence Solutions(RWE) for Oncology Business (2020-2025)

Figure 51. ICON Plc Revenue Growth Rate in Real World Evidence Solutions(RWE) for Oncology Business (2020-2025)

Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Real World Evidence Solutions(RWE) for Oncology Business (2020-2025)

Figure 53. Clinigen Revenue Growth Rate in Real World Evidence Solutions(RWE) for Oncology Business (2020-2025)

Figure 54. Cognizant Revenue Growth Rate in Real World Evidence Solutions(RWE) for Oncology Business (2020-2025)

Figure 55. Oracle Revenue Growth Rate in Real World Evidence Solutions(RWE) for Oncology Business (2020-2025)

Figure 56. Parexel Revenue Growth Rate in Real World Evidence Solutions(RWE) for Oncology Business (2020-2025)

Figure 57. PerkinElmer Revenue Growth Rate in Real World Evidence Solutions(RWE) for Oncology Business (2020-2025)

Figure 58. IBM Revenue Growth Rate in Real World Evidence Solutions(RWE) for Oncology Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Women s Oncology Detection Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Real World Evidence in Healthcare Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Radiation Oncology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Evidence Management Software Market Research Report 2024

Rad Hard Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Clinical Trial Imaging System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Real Time Inventory Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

eCOA and ePRO Solutions for Clinical Trials Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

In Vitro Cancer Diagnostic Reagent Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Clinical Workflow Solution Market Research Report 2024

Oncology Radiopharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

AI In Oncology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Real World Evidence Solution Market Research Report 2024

Global Real World Data Solution Market Research Report 2024

Global Real World Data Solution in Medical Market Research Report 2024

Oncology Blood Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Clinical Trials Matching Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Radiotherapy Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Real Time PCR Reagents Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions